Opening Asia for Russia

Malaysians are waiting for a license from the authorities to use Sputnik V

21.05.2021 48 просмотров

The Malaysian authorities may issue a license for the Sputnik V vaccine before the end of the month.

The Malaysian pharmaceutical company Duopharma Sdn Bhd expects to receive a license from the authorities by the end of the month to use the Russian Sputnik V coronavirus vaccine in the country. This was reported by the Malaysian Reserve publication on Friday, citing the company's managing director Leonard Shatar.

“We have secured the support of the government and the national pharmaceutical regulatory agency and hope to obtain a license as soon as possible” - said the head of the company. He expects that "this can be done before May 31." “We are interested in supporting the national vaccination program,” said Leonard Shatar.

According to him, Duopharma's production facilities are "ready to produce various types of vaccines." In addition, "the company's planned investments in vaccine production are aligned with the government's long-term goal of ensuring the necessary stock of domestic vaccines," the managing director said.

On January 26, a Malaysian company signed an agreement with the Russian Direct Investment Fund on the terms of delivery of vaccines to Malaysia "Sputnik V".

Новости партнёров